[1] HUANG Shaohui CHEN Weicong SUN Haitao GAO Lei ZHANG Guohua ZHANG Xufu AN Haiyan PANG Jie HE Songqi,.Professor LYU Zhipings Academic Experience in Treatment of Hepatobiliary diseases [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2022, (01): 28-33. [doi: 10.13424/j.cnki.jsctcm.2022.01.007]
Copy

Professor LYU Zhipings Academic Experience in Treatment of Hepatobiliary diseases

Journal of Shaanxi University of Traditional Chinese Medicine[ISSN: 2096-1340/ CN: 61-1501/R] Volumes & Issues: 2022 01 pagination: 28-33 Column: Publication date: 2022-02-01
Article number:
2096-1340(2022)01-0028-06
Author(s):
HUANG Shaohui1 CHEN Weicong1 SUN Haitao1 GAO Lei1 ZHANG Guohua1 ZHANG Xufu1 AN Haiyan1 PANG Jie1 HE Songqi1; 2
1.Southern Medical University,Guangzhou 510515,China;
2.Integrated Traditional Chinese and Western Medicine Hospital of Southern Medical University,Guangzhou 510315,China
Keywords:
Key words： Hepatobiliary disease; Liver and spleen diseases; Soothing liver; Strengthening spleen and regulating Qi; Inheritance of famous doctors; LYU Zhiping
ZTFLH:
R256.4
DOI:
10.13424/j.cnki.jsctcm.2022.01.007
Code:
A
Abstract:
Abstract： This paper summarizes Professor LYU Zhipings experience in the prevention and treatment of hepatobiliary diseases under the guidance of the academic viewpoint of “regulating liver and calming five Zang organs”.It comprehensively discusses the theoretical origin of “soothing the liver,strengthening the spleen and regulating Qi” of hepatobiliary diseases,deeply analyzes the transmission and prevention thought of liver disease transmitting the spleen and enriching the spleen first,and expounds the pathogenesis characteristics of liver and biliary diseases,as well as the syndrome evolution law of liver and spleen diseases with liver disease transmitting the spleen from excess to deficiency and mixed deficiency and excess.The characteristics and practical experience of Professor LYU Zhiping in the treatment of common hepatobiliary diseases are analyzed in detail.

References:

［1］刘大荣.名老中医关汝耀副教授的学术思想简介［J］.新中医，1987，(3)：11-13.
［2］王小平，魏凤琴.张珍玉医案医论医话集［M］.北京：人民卫生出版社，2010：2-281.
［3］李德新.李德新中医基础理论讲稿［M］.北京：人民卫生出版社，2008：1-562.
［4］孙广仁.中医基础理论［M］.北京：中国中医药出版社，2017：3-315.
［5］吕乃达，焦志刚，刘淑琰.中西医对肝脏解剖学的比较及认识［J］.内蒙古中医药，2001，20(S1)：86-87.
［6］中华医学会感染病学分会，肝脏炎症及其防治专家共识专家委员会.肝脏炎症及其防治专家共识［J］.中华肝脏病杂志，2014，22(2)：94-103.
［7］Duran SR，Jaquiss R.Hepatocellular Carcinoma［J］.N Engl J Med，2019，381(1)：e2.
［8］周登威，徐志伟，孙海娇，等.岭南湿热病证理论的学术源流［J］.中华中医药杂志，2019，34(7)：2901-2904.
［9］徐志伟，吴皓萌，刘小斌，等.岭南医学流派的形成与特色［J］.中华中医药杂志，2015，30(7)：2272-2274.
［10］中华中医药学会肝胆病分会.病毒性肝炎中医辨证标准(2017年版)［J］.中西医结合肝病杂志，2017，27(3)：193-194.
［11］李军祥，陈誩，姚树坤.肝纤维化中西医结合诊疗共识意见(2017年)［J］.中国中西医结合消化杂志，2017，25(12)：895-900.
［12］吕志平，贺松其，张绪富，等.保肝宁抗肝纤维化的治疗作用探析［J］.上海中医药杂志，2005，39(5)：6-8.
［13］贺松其，吕志平，张绪富.保肝宁治疗慢性乙型肝炎肝纤维化128例疗效观察［J］.新中医，2008，40(4)：24-25.
［14］张晓刚，吕志平，钟小兰，等.隐证型慢性乙型肝炎129例临床、生化分析及治疗思路［J］.陕西中医，2006，27(5)：570-571.
［15］喻方亭，吕志平，俞守义，等.中药养肝降酶丸治疗单项转氨酶升高333例［J］.深圳中西医结合杂志，1997，(1)：9-10.
［16］中华医学会感染病学分会，中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)［J］.实用肝脏病杂志，2020，23(1)：插9插32.
［17］曹艳平，隋洪婷，潘猛，等.恩替卡韦联合聚乙二醇干扰素或胸腺素治疗代偿期乙型肝炎肝硬化2年疗效随访［J］.实用肝脏病杂志，2019，22(1)：93-96.
［18］林洪生.恶性肿瘤中医诊疗指南［M］.北京：人民卫生出版社，2014：371-378.
［19］中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版)［J］.中国实用外科杂志，2020，40(2)：121-138.
［20］葛均波，林果为，王吉耀，等.实用内科学［M］.北京：人民卫生出版社，2017：1954-1957.

Memo

基金项目：全国名老中医药专家传承工作室项目（国中医药人教发［2016］42号）；第四批全国中医临床优秀人才研修项目（国中医人教发［2017］24号）

Last Update: 2022-02-10
Copyright @ 2020 Journal of Shaanxi University of Chinese Medicine
 Address: Middle Section of Century Avenue, Xianyang, Shaanxi Province. Post Code: 712046
Tel: 029-38185250 Fax: 029-38185250 E-mail: shxzhzs@163.com Powered by: www.editorhome.cn